UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes Journal article
Wang, Kewei, Li, Zixi, Xuan, Ying, Zhao, Yong, Deng, Chao, Wang, Meidan, Xie, Chenjun, Yuan, Fenglai, Pang, Qingfeng, Mao, Wenjun, Cai, Dongyan, Zhong, Zhangfeng, Mei, Jie. Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes[J]. Cancer Cell International, 2023, 23(1), 229.
Authors:  Wang, Kewei;  Li, Zixi;  Xuan, Ying;  Zhao, Yong;  Deng, Chao; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:5.3/5.0 | Submit date:2024/01/02
Biomarker  Immunotherapy  Nfe2l2  Ngs  Nsclc  
Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets Journal article
Zeng,Chenming, Zhao,Chenxi, Ge,Fujing, Li,Yuekang, Cao,Ji, Ying,Meidan, Lu,Jinjian, He,Qiaojun, Yang,Bo, Dai,Xiaoyang, Zhu,Hong. Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets[J]. Frontiers in Pharmacology, 2020, 11, 1311.
Authors:  Zeng,Chenming;  Zhao,Chenxi;  Ge,Fujing;  Li,Yuekang;  Cao,Ji; et al.
Favorite | TC[WOS]:21 TC[Scopus]:25  IF:4.4/5.0 | Submit date:2021/03/02
Cancer Therapy  Cellular Functions  Deubiquitinase  Machado-joseph Domain-containing Proteases  Mjd Disease